FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
fj.08-107268v1
fj.08-107268v2
22/12/4258    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Léveillé, F.
Right arrow Articles by Buisson, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Léveillé, F.
Right arrow Articles by Buisson, A.
Published online before print September 12, 2008 as doi: 10.1096/fj.08-107268.

Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors

F. Léveillé, F. El gaamouch, E. Gouix, M. Lecocq, D. Lobner, O. Nicole, and A. Buisson

E-mail contact: buisson@cyceron.fr

N-methyl-D-aspartate receptors (NMDARs) are critical for synaptic plasticity that underlies learning and memory. But, they have also been described as a common source of neuronal damage during stroke and neurodegenerative diseases. Several studies have suggested that cellular location of NMDARs (synaptic or extrasynaptic) is a key parameter controlling their effect on neuronal viability. The aim of the study was to understand the relation between these two pools of receptors and to determine their implication in both beneficial and/or deleterious events related to NMDAR activation. We demonstrated that selective extrasynaptic NMDAR activation, as well as NMDA bath application, does not activate extracellular signal-regulated kinase (ERK) pathways, but induces mitochondrial membrane potential breakdown and triggers cell body and dendrite damages, whereas synaptic NMDAR activation is innocuous and induces a sustained ERK activation. The functional dichotomy between these two NMDAR pools is tightly controlled by glutamate uptake systems. Finally, we demonstrated that the only clinically approved NMDAR antagonist, memantine, preferentially antagonizes extrasynaptic NMDARs. Together, these results suggest that extrasynaptic NMDAR activation contributes to excitotoxicity and that a selective targeting of the extrasynaptic NMDARs represents a promising therapeutic strategy for brain injuries.—Léveillé, F., El gaamouch, F., Gouix, E., Lecocq, M., Lobner, D., Nicole, O., Buisson, A. Neuronal viability is controlled by a functional relation between synaptic and extrasynaptic NMDA receptors.




This article has been cited by other articles:


Home page
 Mol. Endocrinol.Home page
L. Xiao, C. Feng, and Y. Chen
Glucocorticoid Rapidly Enhances NMDA-Evoked Neurotoxicity by Attenuating the NR2A-Containing NMDA Receptor-Mediated ERK1/2 Activation
Mol. Endocrinol., March 1, 2010; 24(3): 497 - 510.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
C. Lopez-Menendez, S. Gascon, M. Sobrado, O. G. Vidaurre, A. M. Higuero, A. Rodriguez-Pena, T. Iglesias, and M. Diaz-Guerra
Kidins220/ARMS downregulation by excitotoxic activation of NMDARs reveals its involvement in neuronal survival and death pathways
J. Cell Sci., October 1, 2009; 122(19): 3554 - 3565.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
J. Xu, P. Kurup, Y. Zhang, S. M. Goebel-Goody, P. H. Wu, A. H. Hawasli, M. L. Baum, J. A. Bibb, and P. J. Lombroso
Extrasynaptic NMDA Receptors Couple Preferentially to Excitotoxicity via Calpain-Mediated Cleavage of STEP
J. Neurosci., July 22, 2009; 29(29): 9330 - 9343.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
M. Y. Heng, P. J. Detloff, P. L. Wang, J. Z. Tsien, and R. L. Albin
In Vivo Evidence for NMDA Receptor-Mediated Excitotoxicity in a Murine Genetic Model of Huntington Disease
J. Neurosci., March 11, 2009; 29(10): 3200 - 3205.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
P. R. Joshi, N.-P. Wu, V. M. Andre, D. M. Cummings, C. Cepeda, J. A. Joyce, J. B. Carroll, B. R. Leavitt, M. R. Hayden, M. S. Levine, et al.
Age-Dependent Alterations of Corticostriatal Activity in the YAC128 Mouse Model of Huntington Disease
J. Neurosci., February 25, 2009; 29(8): 2414 - 2427.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by The Federation of American Societies for Experimental Biology.